Literature DB >> 8193553

Biochemical characterization of the O-glycans on recombinant glycophorin A expressed in Chinese hamster ovary cells.

P Påhlsson1, D P Blackall, M Ugorski, M Czerwinski, S L Spitalnik.   

Abstract

Alterations in N- and O-linked glycosylation affect cell surface expression and antigenicity of recombinant glycophorin A expressed in transfected Chinese hamster ovary (CHO) cells. To understand these effects further, glycophorin A was purified by immunoaffinity chromatography from transfected wild type and glycosylation deficient CHO cells. The O-glycans were characterized both biochemically, using gel filtration and high performance anion exchange chromatography, and immunologically, using carbohydrate specific monoclonal antibodies to probe Western blots. The O-glycans of human erythrocyte glycophorin A consist mainly of short oligosaccharides with one, two, or three sialic acid residues linked to a common disaccharide core, Gal beta 1-3GalNAc alpha 1-Ser/Thr, with the disialylated structure being the most abundant. With the exception of the trisialylated derivative, the same structures were found on recombinant glycophorin A expressed by wild type CHO cells. However, in contrast to human erythrocyte glycophorin A, the monosialylated oligosaccharide was the most abundant structure on the recombinant protein. Furthermore, recombinant glycophorin A was shown to express a small amount of the Tn antigen (GalNAc alpha 1-Ser/Thr). Recombinant glycophorin A had the same O-glycan composition, whether purified from clones expressing high or moderate levels of the recombinant glycoprotein. This indicates that the level of expression of the transfected glycoprotein did not affect its O-glycan composition. Deletion of the N-linked glycosylation site at Asn26, by introducing the Mi.I mutation (Thr28-->Met) by site-directed mutagenesis, did not markedly affect the O-glycan composition of the resulting recombinant glycoprotein expressed in wild type CHO cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193553     DOI: 10.1007/bf00732431

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  52 in total

1.  Characterization of the epitope recognized by a monoclonal antibody highly specific for blood group M antigen.

Authors:  E Jaskiewicz; J J Moulds; K Kraemer; A S Goldstein; E Lisowska
Journal:  Transfusion       Date:  1990 Mar-Apr       Impact factor: 3.157

2.  A monoclonal anti-glycophorin A antibody recognizing the blood group M determinant: studies on the subspecificity.

Authors:  E Lisowska; L Messeter; M Duk; M Czerwiński; A Lundblad
Journal:  Mol Immunol       Date:  1987-06       Impact factor: 4.407

3.  BioGel P-4 column chromatography of oligosaccharides: effective size of oligosaccharides expressed in glucose units.

Authors:  A Kobata; K Yamashita; S Takasaki
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Immunochemical characteristics of human anti-T antibodies.

Authors:  Y D Kim
Journal:  Vox Sang       Date:  1980-09       Impact factor: 2.144

6.  The binding of human alloantibodies to recombinant glycophorin A.

Authors:  D P Blackall; M Ugorski; M E Smith; P Påhlsson; S L Spitalnik
Journal:  Transfusion       Date:  1992-09       Impact factor: 3.157

7.  Structures of the asparagine-linked sugar chains of glycophorin A.

Authors:  H Yoshima; H Furthmayr; A Kobata
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

8.  Structural analysis of the carbohydrate chains of a mouse monoclonal IgM antibody.

Authors:  H Krotkiewski; B Nilsson; S Svensson
Journal:  Eur J Biochem       Date:  1989-09-01

9.  Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.

Authors:  S Hirohashi; H Clausen; T Yamada; Y Shimosato; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Binding specificities of eight monoclonal antibodies to human glycophorin A--studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNV-type chimpanzee erythrocytes.

Authors:  W L Bigbee; R G Langlois; M Vanderlaan; R H Jensen
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  4 in total

Review 1.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

2.  Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Stephanie M Balthazor; Brian R Curtis; Janice G McFarland; Richard H Aster
Journal:  Transfusion       Date:  2005-09       Impact factor: 3.157

3.  Biosynthesis of mucin type O-glycans: lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression.

Authors:  I Brockhausen; F Vavasseur; X Yang
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

4.  Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.

Authors:  N Bannert; S Craig; M Farzan; D Sogah; N V Santo; H Choe; J Sodroski
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.